ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
- PMID: 18826876
- DOI: 10.1016/j.ejheart.2008.08.005
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Erratum in
- Eur J Heart Fail. 2009 Jan;11(1):110
- Eur J Heart Fail. 2010 Apr;12(4):416. Dosage error in article text
Similar articles
-
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur Heart J. 2008 Oct;29(19):2388-442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17. Eur Heart J. 2008. PMID: 18799522 Review. No abstract available.
-
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.Eur J Heart Fail. 2012 Aug;14(8):803-69. doi: 10.1093/eurjhf/hfs105. Eur J Heart Fail. 2012. PMID: 22828712 No abstract available.
-
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20. Eur J Heart Fail. 2016. PMID: 27207191 No abstract available.
-
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.Circulation. 2005 Sep 20;112(12):e154-235. doi: 10.1161/CIRCULATIONAHA.105.167586. Epub 2005 Sep 13. Circulation. 2005. PMID: 16160202 No abstract available.
-
[The new ESC Guidelines for acute and chronic heart failure 2016].Herz. 2016 Dec;41(8):655-663. doi: 10.1007/s00059-016-4496-3. Herz. 2016. PMID: 27858115 Review. German.
Cited by
-
Evaluation of Innate Immunity Biomarkers on Admission and at Discharge From an Acute Heart Failure Episode.J Clin Lab Anal. 2016 Nov;30(6):1183-1190. doi: 10.1002/jcla.22001. Epub 2016 Jul 8. J Clin Lab Anal. 2016. PMID: 27390057 Free PMC article.
-
Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia.J Cachexia Sarcopenia Muscle. 2011 Dec;2(4):191-200. doi: 10.1007/s13539-011-0043-5. Epub 2011 Oct 20. J Cachexia Sarcopenia Muscle. 2011. PMID: 22207907 Free PMC article.
-
Natriuretic peptides in heart failure: where we are, where we are going.Intern Emerg Med. 2011 Feb;6(1):63-8. doi: 10.1007/s11739-010-0438-x. Epub 2010 Sep 18. Intern Emerg Med. 2011. PMID: 20853071 Review.
-
Aging, telomeres and heart failure.Heart Fail Rev. 2010 Sep;15(5):479-86. doi: 10.1007/s10741-010-9173-7. Heart Fail Rev. 2010. PMID: 20532978 Free PMC article. Review.
-
Role of a Novel Silver Fir (Abies alba) Extract, Abigenol®/AlbiPhenol®, in Modulating Cardiovascular Disorders: Key Factors.Antioxidants (Basel). 2022 Mar 23;11(4):618. doi: 10.3390/antiox11040618. Antioxidants (Basel). 2022. PMID: 35453303 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical